|
|
Volumn 38, Issue 1, 2005, Pages 39-40
|
|
Augmentation of clozapine with amisulpride: A promising therapeutic approach to refractory schizophrenic symptoms - Letter to the editor
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMISULPRIDE;
ATYPICAL ANTIPSYCHOTIC AGENT;
CLOZAPINE;
DOPAMINE 2 RECEPTOR;
DOPAMINE 3 RECEPTOR;
ADD ON THERAPY;
ADULT;
BASAL GANGLION;
CLINICAL ARTICLE;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG POTENTIATION;
HUMAN;
LETTER;
LEUKOPENIA;
MONOTHERAPY;
NEGATIVE SYNDROME;
PARANOID SCHIZOPHRENIA;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
QT INTERVAL;
RECEPTOR OCCUPANCY;
RETROSPECTIVE STUDY;
SCHIZOAFFECTIVE PSYCHOSIS;
SCHIZOPHRENIA;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
ADULT;
ANTIPSYCHOTIC AGENTS;
CLOZAPINE;
DRUG SYNERGISM;
DRUG THERAPY, COMBINATION;
HUMANS;
SCHIZOPHRENIA;
SCHIZOPHRENIC PSYCHOLOGY;
SULPIRIDE;
|
|
EID: 14044254736
PISSN: 01763679
EISSN: None
Source Type: Journal
DOI: 10.1055/s-2005-837772 Document Type: Letter |
|
Times cited : (27)
|
|
References (6)
|
